IHL
REGN icon

Investment House LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Investment House LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Hold
525
– – 0.01% 196
2026
Q1 		$406K Sell
525
-15
-3% -$11.5K 0.02% 179
2025
Q4 		$417K Sell
540
-117
-18% -$79.5K 0.02% 178
2025
Q3 		$369K Hold
657
– – 0.02% 192
2025
Q2 		$345K Sell
657
-32
-5% -$17.9K 0.02% 191
2025
Q1 		$437K Hold
689
– – 0.02% 182
2024
Q4 		$491K Hold
689
– – 0.03% 164
2024
Q3 		$724K Sell
689
-10
-1% -$11.1K 0.04% 156
2024
Q2 		$735K Hold
699
– – 0.04% 144
2024
Q1 		$673K Hold
699
– – 0.04% 149
2023
Q4 		$614K Sell
699
-16
-2% -$13.2K 0.04% 142
2023
Q3 		$588K Sell
715
-450
-39% -$354K 0.05% 134
2023
Q2 		$837K Hold
1,165
– – 0.06% 126
2023
Q1 		$957K Hold
1,165
– – 0.08% 116
2022
Q4 		$841K Hold
1,165
– – 0.08% 105
2022
Q3 		$803K Sell
1,165
-30
-3% -$18.9K 0.08% 113
2022
Q2 		$706K Hold
1,195
– – 0.06% 115
2022
Q1 		$835K Hold
1,195
– – 0.06% 115
2021
Q4 		$755K Hold
1,195
– – 0.05% 125
2021
Q3 		$723K Hold
1,195
– – 0.05% 128
2021
Q2 		$667K Hold
1,195
– – 0.05% 137
2021
Q1 		$565K Hold
1,195
– – 0.04% 135
2020
Q4 		$577K Hold
1,195
– – 0.04% 147
2020
Q3 		$669K Hold
1,195
– – 0.05% 133
2020
Q2 		$745K Sell
1,195
-15
-1% -$8.51K 0.07% 121
2020
Q1 		$591K Buy
1,210
+30
+3% +$12.4K 0.07% 121
2019
Q4 		$443K Sell
1,180
-50
-4% -$16.8K 0.04% 161
2019
Q3 		$341K Sell
1,230
-723
-37% -$214K 0.03% 159
2019
Q2 		$611K Sell
1,953
-60
-3% -$20K 0.06% 130
2019
Q1 		$827K Buy
2,013
+180
+10% +$74.1K 0.09% 123
2018
Q4 		$685K Sell
1,833
-105
-5% -$38.4K 0.09% 116
2018
Q3 		$783K Sell
1,938
-5
-0.3% -$1.9K 0.08% 118
2018
Q2 		$670K Sell
1,943
-455
-19% -$142K 0.08% 127
2018
Q1 		$826K Buy
+2,398
New +$834K 0.1% 115

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Investment House LLC's REGN Position: Q2 2026 in Review

Investment House LLC held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 525 shares worth $327K. The position accounts for 0.01% of the portfolio, ranked #196.

Investment House LLC first reported a position in REGN in Q1 2018 and has held it in 34 quarters since. The position peaked at $957K in Q1 2023. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Investment House LLC held 525 shares of Regeneron Pharmaceuticals worth $327K as of Q2 2026.
  • Investment House LLC left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Investment House LLC's portfolio in Q2 2026, its #196 holding.
  • Investment House LLC first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 34 quarters since.
  • Investment House LLC's Regeneron Pharmaceuticals position peaked at $957K in Q1 2023.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Investment House LLC's 13F filing for Q2 2026, filed 21 Jul 2026.